Parkinson's disease (PD) is a neurodegenerative disorder that primarily affects dopamine-producing neurons in the substantia nigra, a region of the brain. This article aims to provide a comprehensive understanding of the disease, its pathogenesis, clinical features, diagnosis, and management strategies.
The hallmark of PD is the progressive loss of dopamine-producing neurons, leading to a decrease in striatal dopamine levels. This imbalance disrupts normal brain function, resulting in the characteristic motor symptoms of PD: bradykinesia, resting tremor, rigidity, and postural instability. Non-motor symptoms such as cognitive impairment, depression, and autonomic dysfunction may also occur.
Diagnosis of PD is primarily clinical and based on the presence of cardinal motor symptoms. Neuroimaging techniques like DaTscan can support the diagnosis, but they are not routinely used due to their high cost and limited availability. There are no definitive biomarkers for PD, making early diagnosis challenging.
Management of PD involves a multidisciplinary approach. Pharmacological treatment primarily aims to replace or mimic dopamine, with Levodopa being the most effective drug. Deep Brain Stimulation (DBS) is a surgical option for patients with advanced PD or those who do not respond to medication. Non-pharmacological interventions, including physiotherapy and occupational therapy, are also crucial in managing PD symptoms and improving quality of life.
Research is ongoing to develop disease-modifying therapies that can slow or halt the progression of PD. Genetic and environmental risk factors are being explored to understand their role in PD pathogenesis and to identify potential therapeutic targets.
Understanding Parkinson's disease requires a comprehensive approach, incorporating knowledge of its pathogenesis, clinical features, diagnostic challenges, and management strategies. As healthcare professionals, staying updated on the latest research and advancements can enable us to provide optimal care to our patients.
1.
Tumor characteristics found to differ for melanomas in children, teens and young adults
2.
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials
3.
"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.
4.
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
5.
Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?
1.
Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care
2.
Screening for Early Therapy-Related Cancer Susceptibility
3.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
4.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
5.
Reducing Modifiable Childhood Cancer Exposure Risks
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
2.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
3.
Should We Use DARA Up Front As First-Line Therapy in MM?
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
5.
Importance of Cancer Screening and Early Detection
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation